Eric Lu
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
-
- Sarcoma Diagnosis and Treatment 2
- Prostate Cancer Treatment and Research 2
- Renal cell carcinoma treatment 1
- Co-authors
- Ko‐Hsiu Lu (6 shared papers)Chiao‐Wen Lin (5 shared papers)Shun‐Fa Yang (5 shared papers)Jia‐Sin Yang (3 shared papers)Joseph J. Shatzel (2 shared papers)Jose Rueda (1 shared paper)Thomas G. DeLoughery (1 shared paper)Sven R. Olson (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Matrix Biology (1 paper)Clinical Genitourinary Cancer (1 paper)International Journal of Biological Sciences (1 paper)American Journal of Nephrology (1 paper)
- Partner nations
- United StatesTaiwanCanada
In The Last Decade
Eric Lu
18 papers receiving 320 citations
Peers
Comparison fields: 5 of 69
- Molecular Medicine 34
- Cancer Research 43
- Toxicology 10
- Nephrology 18
- Immunology 52
Countries citing papers authored by Eric Lu
This map shows the geographic impact of Eric Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Lu more than expected).
Fields of papers citing papers by Eric Lu
This network shows the impact of papers produced by Eric Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Lu. The network helps show where Eric Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 67 | |
| 2 | 2023 | 44 | |
| 3 | 2018 | 42 | |
| 4 | 2023 | 30 | |
| 5 | 2021 | 29 | |
| 6 | 2021 | 19 | |
| 7 | 2021 | 18 | |
| 8 | 2021 | 16 | |
| 9 | 2017 | 14 | |
| 10 | 2020 | 9 | |
| 11 | 2018 | 8 | |
| 12 | 2018 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2025 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2024 | 0 |
About Eric Lu
Eric Lu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Nephrology, having authored 19 papers that have together received 321 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Sarcoma Diagnosis and Treatment (2 papers), RNA Interference and Gene Delivery (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Prostate Cancer Treatment and Research (2 papers), Urinary and Genital Oncology Studies (2 papers), Traumatic Brain Injury and Neurovascular Disturbances (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Molecular Medicine (34 citations), Cancer Research (43 citations), Toxicology (10 citations), Nephrology (18 citations) and Immunology (52 citations). Eric Lu has collaborated with scholars based in United States, Taiwan and Canada. Frequent co-authors include Ko‐Hsiu Lu, Chiao‐Wen Lin, Shun‐Fa Yang, Jia‐Sin Yang, Joseph J. Shatzel, Jose Rueda, Thomas G. DeLoughery, Sven R. Olson, Chih‐Hsin Tang and Yi‐Hsien Hsieh. Their work appears in journals such as Journal of Clinical Oncology, Matrix Biology, Clinical Genitourinary Cancer, International Journal of Biological Sciences and American Journal of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.